"Driven by the rapid growth of our customer engagements and increasing pace of customer interactions, and in full accordance with our business plan, I am pleased to announce the addition of four new senior executives to our commercial development team. These new appointments include some of the most experienced, highly respected commercial development professionals in the drug delivery device industry."
Come on Al, fill in the gaps - who are these new executives? Ramping them up nicely but missed a key ingredient, so at least give holders the opportunity to find out more about these people.
UNS Price at posting:
45.0¢ Sentiment: Hold Disclosure: Not Held